share_log

Allogene Therapeutics | 8-K: Allogene Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update

SEC announcement ·  Mar 14 16:17
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more